Clin Lab. 2022 Mar 1;68(3). doi: 10.7754/Clin.Lab.2021.210541.
To compare MMA-related gene mutations in MMA children and the population in Qingdao, discuss the blood propionyl carnitine (C3), free carnitine (C0) methionine (MET), the mutual ratio and division difference in normal group, carrier group, and MMA group to analyze the relationship between some hotspot mutations and biochemical indicators.
In total 3,700 newborns testing negative in tandem mass spectrometry (MS/MS) were selected at random and submitted for testing 8 pathogenic sites in MMACHC and 10 in MMUT. The gene mutations in 84 cases with detected mutation genes and 42 diagnosed children were compared. The levels and concentration distribution of C3, C0, MET, C3/C2, C3/C0, C3/MET in the blood samples of three groups were analyzed as well as the difference of biochemical indicators in newborns with hotspot mutations (c.609A>G, c.482G>A, and c.658-660delAAG).
All 8 pathogenic mutations in MMACHC in the population were detected and were basically consistent with the mutation types and frequency order in MMA group. The first three were c.609G>A, c.482G>A, and c.658_660delAAG. There were more types of mutation sites detected in MMA group than carrier group. Five out of 10 MMUT gene mutations were detected in the population, and 9 MMUT gene mutation sites were detected in MMA group. The findings in the two groups and the preset sites were not completely consistent. C3, C0, C3/C2, C3/C0, C3/MET in MMA group were higher than carrier and normal groups, and the difference was statistically significant; the MET in MMA group was lower than carrier and normal groups, and the difference was statistical¬ly significant. Based on the three sets of data distribution graphs, C3, C3/C2, C3/C0, and C3/MET were well distinguished. There were differences in the average C3 and C0 levels between carrier and normal groups, but with an obvious cross distribution in the graphs, and no difference in other indicators. In contrast to non-carrier group, C0, C3, C3/C0, C3/C2, and C3/MET concentration levels were higher in 609A>G mutation group, while MET level was lower, with statistical significance; in c.482G>A mutation group, C3, C3/C0, C3/C2, and C3/MET concentration levels were lower than non-carrier group, while MET level was higher, with statistical significance; in c.658-660delAAG mutation group, C0, C3, C3/C0, C3/C2, MET, and C3/MET concentration levels were not statistically different in contrast to other groups.
The top three mutations in MMA children in Qingdao area are c.609A>G, c.482G>A, c.658-660del AAG mutations in MMAHC; C3, C3/C2, C3/C0 can be used as specific prompt indicators for MMA screening; C3, C3/C2, C3/C0, C3/MET can be used as specific prompt indicators for combined MMA screening; abnormalities in biochemical indicators in hotspot mutation group intuitively explains c.609A>G mutation and early-onset MMA. c.482G>A mutation links with late-onset MMA.
比较 MMA 患儿与青岛人群 MMA 相关基因突变,探讨血丙酰肉碱(C3)、游离肉碱(C0)、蛋氨酸(MET)、正常组、携带者组和 MMA 组的相互比值和差异,分析部分热点突变与生化指标的关系。
随机选取串联质谱(MS/MS)检测阴性的 3700 例新生儿,检测 MMACHC 中 8 个致病基因和 MMUT 中 10 个基因的突变。比较 84 例检出突变基因和 42 例确诊患儿的基因突变。分析三组人群血 C3、C0、MET、C3/C2、C3/C0、C3/MET 水平及浓度分布,分析携带热点突变(c.609A>G、c.482G>A、c.658-660delAAG)新生儿的生化指标差异。
人群中 MMACHC 的 8 个致病性突变均被检出,与 MMA 组的突变类型和频率顺序基本一致。前 3 位分别是 c.609G>A、c.482G>A、c.658_660delAAG。MMA 组突变位点类型多于携带者组。人群中检测到 10 个 MMUT 基因突变中的 5 个,MMA 组检测到 9 个 MMUT 基因突变。两组和预设位点的发现不完全一致。MMA 组 C3、C0、C3/C2、C3/C0、C3/MET 均高于携带者和正常组,差异有统计学意义;MMA 组 MET 低于携带者和正常组,差异有统计学意义。根据三组数据分布图谱,C3、C3/C2、C3/C0、C3/MET 区分较好。携带者和正常组 C3、C0 水平存在差异,但图谱分布明显交叉,其他指标无差异。与非携带者组相比,609A>G 突变组 C0、C3、C3/C0、C3/C2、C3/MET 浓度水平较高,MET 水平较低,差异有统计学意义;c.482G>A 突变组 C3、C3/C0、C3/C2、C3/MET 浓度水平低于非携带者组,MET 水平较高,差异有统计学意义;c.658-660delAAG 突变组 C0、C3、C3/C0、C3/C2、MET、C3/MET 浓度水平与其他组相比无统计学差异。
青岛地区 MMA 患儿前 3 位突变是 MMAHC 的 c.609A>G、c.482G>A、c.658-660delAAG 突变;C3、C3/C2、C3/C0 可作为 MMA 筛查的特异性提示指标;C3、C3/C2、C3/C0、C3/MET 可作为 MMA 联合筛查的特异性提示指标;热点突变组生化指标异常直观地解释了 c.609A>G 突变与早发型 MMA 有关,c.482G>A 突变与晚发型 MMA 有关。